Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) EPS (Basic): 2018-2020

Historic EPS (Basic) for Genmab A (GMAB) over the last 3 years, with Dec 2020 value amounting to $8.48.

  • Genmab A's EPS (Basic) rose 360.02% to $1.99 in Q2 2021 from the same period last year, while for Jun 2021 it was $4.24, marking a year-over-year increase of 141.94%. This contributed to the annual value of $8.48 for FY2020, which is 137.05% up from last year.
  • Genmab A's EPS (Basic) amounted to $8.48 in FY2020, which was up 137.05% from $3.58 recorded in FY2019.
  • Over the past 5 years, Genmab A's EPS (Basic) peaked at $8.48 during FY2020, and registered a low of $2.66 during FY2018.
  • In the last 3 years, Genmab A's EPS (Basic) had a median value of $3.58 in 2019 and averaged $4.90.
  • Data for Genmab A's EPS (Basic) shows a peak YoY skyrocketed of 137.05% (in 2020) over the last 5 years.
  • Over the past 3 years, Genmab A's EPS (Basic) (Yearly) stood at $2.66 in 2018, then skyrocketed by 34.65% to $3.58 in 2019, then spiked by 137.05% to $8.48 in 2020.